[1] briefing note about activity of editorial board of “rational pharmacotherapy in cardiology” in 2012

[2] effects of beta-blocker metoprolol on quality of life in elderly patients with chronic heart failure

[3] results and comments on advance study

[4] features of the in-hospital course of myocardial infarction in patients with glucose metabolism disorders

[5] benefits and risks of clopidogrel vs. aspirin monotherapy after recent ischemic stroke: a systematic review and meta-analysis

[6] renal denervation in resistant arterial hypertension

[7] metoprolol and carvedilol in therapy of acute myocardial infarction: when and which drug to prefer

[8] modern approaches to anticoagulant therapy during catheter ablation treatment of non-valvular atrial fibrillation

[9] a comparative study of efficacy and tolerability of generic and original low-dose bisoprolol/hydrochlorothiazide combination in patients with arterial hypertension of 1-2 degrees. results of clinical randomized crossover study

[10] resistance to acetylsalicylic acid and prevalence of thrombosis in patients with stable angina

[11] current target of antihypertensive therapy. data from clinical trials. part 1

[12] nicotine replacement therapy of the tobacco addiction in prevention of cardiorespiratory diseases

[13] prevalence of arterial hypertension, associated diseases and end-organ damages in republic of bashkortostan

[14] anticoagulant therapy in patients with non-valvular atrial fibrillation: drug choice and dosage adjustment

[15] comments on american college of cardiology, american heart association and european society of cardiology guidelines (2006) for the management of patients with atrial fibrillation

[16] dihydropyridine calcium antagonists: data of evidence based medicine and recom-mendations on practical use

[17] safari - randomised trial on complex therapy of arterial hypertension and dislipidemy. the main results

[18] search for universal combined antihypertensive therapy within limited data on the comparative efficacy of antihypertensive agents

[19] russian national congress of cardiologists and congress of cardiologists of cis states

[20] association between heart rate variability and components of the metabolic syndrome in women with rheumatoid arthritis

[21] david m. aronov is 80

[22] effect of spirapril on the length of interictal interval in paroxysmal atrial fibrillation

[23] antiplatelet therapy control: credibility gap or search for new decisions?

[24] urapidil: modern medicine for the treatment of hypertensive crises

[25] guidelines on diabetes, pre-diabetes, and cardiovascular diseases

[26] american college of cardiology, american heart association and european society of cardiology guidelines (2006) for the management of patients with atrial fibrillation (ending)

[27] academician e.i. chazov – 80 years old

[28] the first experience of left atrial appendage occluding devices implantation for prevention of stroke in the state research centre for preventive medicine

[29] «memories of future»: change in verapamil significance in the treatment of patients with ischemic heart disease and arterial hypertension

[30] neoatherosclerosis in the stent

[31] the first russian register of patients with chronic heart failure and atrial fibrillation (rif-chf): study design

[32] comparative evaluation of enalapril and diltiazem efficacy in menopausal women with arterial hypertension

[33] effect of different glucose blood levels on the development of cardiovascular diseases and complications

[34] on the anniversary of academician a.i. martynov

[35] arterial hypertension in russia: prolog study as a proof method of contemporary therapy opportunities

[36] the assessment of effects of combined therapy with mildronate on lipid profile, inflammatory factors and endothelium function in patients with ischemic heart disease

[37] antiplatelet drugs resistance in patients with ischemic heart disease and obliterative atherosclerosis of lower limb arteries associated with diabetes mellitus type 2

[38] primary prevention of myocardial infarction in middle-aged males (15-year follow-up): clinical and economic aspects of the problem

[39] comparative efficacy of amiodarone and bisoprolol in treatment of ventricular premature beats in patients with metabolic syndrome

[40] guidelines on the diagnosis and management of acute pulmonary embolism

[41] changes in the parameters of 24-hour blood pressure monitoring and arterial stiffness in patients with hypertension and chronic obstructive pulmonary disease treated with valsartan

[42] cardiological management of pregnant women in the udmurt republic

[43] effects of atorvastatin on endothelial dysfunction in type 2 diabetic patients with different duration f the disease

[44] resident progenitor cardiac cells in patients with dilated cardiomyopathy and congestive heart failure

[45] three-year dynamics and unsolved problems of lipid-lowering therapy

[46] angiotensin converting enzyme inhibitors and angiotensin receptor blockers: isn't it time to draw a line under discussion about superiority

[47] treatment of patients with severe dyslipidemia in real clinical practice

[48] anticoagulant therapy in everyday clinical practice: data of the retrospective cross-sectional study

[49] depression, anxiety and myocardial infarction: everything just begins (part i)

[50] additional use of trimetazidine in patients with chronic heart failure. a meta-analysis

[51] prevention of thromboembolic complications in atrial fibrillation - rat poison or new oral anticoagulants: do we have a choice, and should we be afraid to make it? first clinical experience with rivaroxaban in nizhny novgorod

[52] new emphases on the study of the pathogenesis of chronic heart failure with preserved ejection fraction: focus on inflammatory markers

[53] assessment of therapeutical equivalency of original and generic indapamide in hypertensive patients by randomized cross-over study

[54] effects of sympathomimetic agents on electrocardiogram indexes in patients with bronchial asthma

[55] pharmacoepidemiology and the efficacy of antihypertensive treatment in real-life practice of the cardiology referral clinic

[56] atrial fibrillation in patients with chronic obstructive pulmonary disease

[57] letter to editor

[58] endothelial adhesive function in patients with ischemic heart disease complicated by chronic heart failure and atrial fibrillation

[59] lercanidipine, calcium channel blocker of the third generation: new possibilities in the treatment of arterial hypertension

[60] use of n-3 polyunsaturated fatty acids 90% (omacor) for therapy and prevention of cardio-vascular diseases

[61] effect of iron and selenium drugs on diastolic myocardial function in patients with anemic cardiomyopathy

[62] school of health for patients with cardio-vascular diseases: balance between andragogic and pedagogic educational models

[63] left ventricular rotation, twist and untwist: physiological role and clinical relevance

[64] magnesium in clinical practice

[65] evaluation of cost-effectiveness of platelet reactivity analysis using the verifynow p2y12 assay in patients after acute coronary syndrome

[66] comparison of the influence of long-term treatment based on carvedilol or bisoprolol on metabolic parameters and erectile function in hypertensive patients with overweight or obesity results of the randomized open-label parallel-groups stepped trial cabriolet (part 2)

[67] syncope in non-massive pulmonary embolism as a predictor of high-risk mortality